
Something good is now actually associated with the name Martin Shkreli: the Food and Drug Administration (FDA) has narrowed a loophole that allowed CEOs of companies from jacking up the prices of older “orphan” drugs to usurious and unethical heights. In case you’ve been binging Netflix for the last year […] keep reading